Percutaneous Heart Valves Tomorrow, Surgical Improvements Today
This article was originally published in Start Up
Executive Summary
According to a report just issued by Health Research International, "Opportunities in Heart Valve Disease Management: Europe, Japan, and Rest of World," sales of heart valves-both the percutaneous and surgical products-will increase almost 9% annually, to $900 million in 2010 in ex-US markets. Driving growth in the market will be a growing tendency to perform valve surgeries concomitantly with coronary artery bypass graft procedures, demographics (an increase in the aged), and emerging markets in developing countries.